Recruiting Advanced Solid Tumors Studies in Adelaide
A Phase 1 Study of [225Ac]-FPI-1434 Injection
This is a first-in-human Phase 1/2, non-randomized, multi-centre, open-label clinical study designed to investigate safety, tolerability, PK, and preliminary anti-tumour activity of \[225Ac\]-FPI-1434...
Phase 1/2a Study of SQ3370 in Patients With Advanced Solid Tumors
The purpose of this study is to evaluate the safety, tolerability, and preliminary activity of SQ3370 in patients with advanced solid tumors....
About Advanced Solid Tumors Clinical Trials in Adelaide
Advanced solid tumors refer to cancers that have grown beyond the original site or spread to distant organs. Many clinical trials enroll patients with various types of advanced solid tumors to test novel therapies. These trials often investigate immunotherapy, targeted therapy, and combination approaches.
There are currently 2 advanced solid tumors clinical trials recruiting participants in Adelaide, SOUTH%20AUSTRAILA. These studies are seeking a combined 398 participants. Research is being sponsored by Fusion Pharmaceuticals Inc., Shasqi, Inc.. Clinical trial participation is free and participants receive study-related medical care at no cost.
Advanced Solid Tumors Clinical Trials in Adelaide — FAQ
Are there advanced solid tumors clinical trials in Adelaide?
Yes, there are 2 advanced solid tumors clinical trials currently recruiting in Adelaide, SOUTH%20AUSTRAILA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Adelaide?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Adelaide research site will contact you about next steps.
Are clinical trials in Adelaide free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Adelaide studies also compensate for your time and travel.
What advanced solid tumors treatments are being tested?
The 2 active trials in Adelaide are testing new therapies including novel drugs, biologics, and treatment approaches for advanced solid tumors.
Data updated March 2, 2026 from ClinicalTrials.gov